Increasing interest for availability of tangible, novel, added value and sustainable commercial exploitable of nature therapeutic compounds including those derived from marine sources have enriched a long history of research into Acanthaster planci Crown-of-thorns (COT) starfish biology, ecology, and the causes of their outbreaks. These are important aspects for a sustainable commercial optimization and exploitation of Acanthaster planci COT especially for health related agendas or therapeutic application. This manuscript thus seeks to outline present and future research strategy and works pertinent to Acanthaster planci COT locally and global focused on evidence-based optimised sustainable exploitation as well as refining management actions to improve the performance of control programs. Among deuterostomes, the regenerative potential is maximally expressed in echinoderms such as the Acanthaster planci COT; these animals can quickly replace most injured organs. In tandem to that, views for further gene related molecular characterization and chemical analysis of potential cell mediated protein from these marine invertebrates that have potential in medical and pharmaceutical therapeutics will be highlighted.

This study aimed to highlight on the influence of exposure to electromagnetic fields (EMFs) on the cardiovascular system in humans and experimental animals, from the recent articles regarding the cardiovascular effects of exposure to EMFs. EMFs might produce a variety of adverse in vivo effects such as heart problems, chest pain, and cardiovascular system disorders. Previous studies showed that an association between elevated magnetic field exposure and mortality of employer in electric utility industry jobs from arrhythmia-related causes and acute myocardial infarction influence heart rate variability by changing autonomic balance. EMF exposure can affect structure and function of cardiovascular system and may facilitate myocardial infarction by nuclear changing of cardiomyocytes. Exposure to EMFs induced pain or pressure in the chest area, heart palpitations, and/or an irregular heart beat. The symptoms resemble a heart attack and thus contribute to even more anxiety. Also, exposure to EMFs caused highly significant increases in the activeties of serum creatinine phosphokinase, lactate dehydrogenase and aspartate amino-transferase enzymes, and decreases in plasma calcium level and total anti-oxidant capacity. Rats exposed to EMF showed increases in blood pressure, the absolute and relative whole heart and left ventricular weights. On the other hand, the heart rate was significantly reduced in rats exposed to EMF.

Tasting salt or Monosodium Glutamate was invented by the Japanese over a century ago. The flavour profile known as Umami, or the fifth taste, after the four tastes of sweet, salty, sour and bitter, was discovered whilst working with sea weed. Umami is a meaty taste that is naturally present in cheese and ripe tomatoes. For more than a 100 years, the flavour of Umami has been artificially manufactured in factories all over the world, starting in Japan. The flavour profile presented by tasting salt offers both packaged and non-packaged food producers with an affordable and openly accessible alternative to flavouring their foods. Home cooks are also offered the product as they are able to openly purchase the salt off the shelf. Hence, a lack of regulation. Presently, tasting salt is present in thousands of food items all over the world, and its use is only increasing. Restaurants use the salt in their dishes as an inexpensive alternative to building complex flavour profiles using meat stock. At the same time, health concerns about the product‟s wide spread use have also been made apparent over the last two decades. Despite the legal system of almost all countries in the world not having put any restriction on tasting salt, the use of the product has been shown to lead to serious health concerns for humans. Hence, the need for ethical business practice to promote public health by going above and beyond legal compliance.